Literature DB >> 3158646

Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.

T Seya, S Nagasawa.   

Abstract

Limited proteolysis of C3b by C3b inactivator (factor I) consists of a two-step reaction; rapid cleavage of C3b to yield a nicked C3b derivative, iC3b, and followed by slow cleavage of iC3b to yield two antigenically distinct fragments, C3c and C3d,g. Using a fluorescence-labeled C3b as a substrate for I, we have investigated in detail the optimal conditions for the sequential cleavages of C3b by I. The pH optimum for the first cleavage was markedly affected by the ionic strength of buffers. The cleavage was maximum at pH 6.0 under physiological ionic strength but at pH 8.5 under low ionic strength (such as 1.7 mS). The second cleavage was a slow reaction and occurred only under low ionic strength and within a narrow pH range around pH 6.0. One of the products of the second cleavage, C3d,g, was isolated and shown to be a single polypeptide chain of 41,000 daltons with pI 5.0. C3d,g had leucocytosis-inducing activity, like C3d-k, which is a C3d fragment released by the action of plasma kallikrein. Trypsin digestion of C3d,g produced two fragments of 30,000 and 10,000 daltons and the 10,000-dalton fragment retained the leucocytosis inducing activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158646     DOI: 10.1093/oxfordjournals.jbchem.a135064

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

Review 1.  C4b-binding protein, a regulatory protein of complement.

Authors:  S R Barnum
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.

Authors:  Michelle Elvington; Yuxiang Huang; B Paul Morgan; Fei Qiao; Nico van Rooijen; Carl Atkinson; Stephen Tomlinson
Journal:  Blood       Date:  2012-03-22       Impact factor: 22.113

3.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.

Authors:  T Seya; S Nagasawa; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Neutrophil mobilization induced by complement fragments during experimental group B streptococcal (GBS) infection.

Authors:  A O Shigeoka; R J Gobel; J Janatova; H R Hill
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

7.  Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.

Authors:  Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard J Smith; Richard R Kew
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

8.  Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.

Authors:  Hongbin Song; Chun He; Christian Knaak; Joel M Guthridge; V Michael Holers; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralizing activity.

Authors:  M Kitamura; M Namiki; K Matsumiya; K Tanaka; M Matsumoto; T Hara; H Kiyohara; M Okabe; A Okuyama; T Seya
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

10.  Functional properties of membrane cofactor protein of complement.

Authors:  T Seya; J P Atkinson
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.